| Announce Date | 03/23/2023 |
| EPS Normalized Actual | $0.18 (Beat by $0.06) |
| EPS GAAP Actual | $0.18 (Beat by $0.06) |
| Revenue Actual | $0.039169B |
| Revenue Surprise | Beat by $39.169M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2033 | 0.35 | 27.11 | 0.35 | 0.35 | 1 |
| Jan 2032 | 0.35 | 27.11 | 0.35 | 0.35 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.05 | 0.05 | 0.039169B | -3.2% | 2.44M |
| FQ3 2025 (Jul 2025) | -0.16 | -0.16 | 0.036102B | -12.29% | -2.26M |
| FQ2 2025 (Apr 2025) | -0.05 | -0.05 | 0.037708B | 12.59% | 37.71M |
| FQ1 2025 (Jan 2025) | -2.07 | -2.07 | 0.037361B | -5.98% | 37.36M |
| FQ4 2024 (Nov 2024) | 0.0319 | -1.50547 | 0.040422B | 7.11% | -34.68M |
| FQ3 2024 (Aug 2024) | -0.0414 | -0.0414 | 0.040539B | 12.37% | 40.54M |
| FQ2 2024 (Apr 2024) | 0.16 | 0.16 | 0.032961B | -7.46% | 32.96M |
| FQ1 2024 (Jan 2024) | 0.36 | 0.36 | 0.039594B | -0.65% | 39.59M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ3 2028 (Jul 2028) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ2 2028 (Apr 2028) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ4 2027 (Oct 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ3 2027 (Jul 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ2 2027 (Apr 2027) | 0.04 | -- | 0.04 | 0.04 | 1 |
| FQ4 2026 (Oct 2026) | 0.02 | -150 | 0.02 | 0.02 | 1 |
| FQ3 2026 (Jul 2026) | -0.06 | -166.67 | -0.06 | -0.06 | 1 |
| FQ2 2026 (Apr 2026) | -0.19 | 73.68 | -0.19 | -0.19 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Oct 2028) | 0.03B | -- | 0.03B | 0.03B | 16 |
| FQ3 2028 (Jul 2028) | 0.03B | -- | 0.03B | 0.03B | 8 |
| FQ2 2028 (Apr 2028) | 0.03B | -- | 0.03B | 0.03B | 9 |
| FQ4 2027 (Oct 2027) | 0.03B | -- | 0.03B | 0.03B | 9 |
| FQ3 2027 (Jul 2027) | 0.03B | -- | 0.03B | 0.03B | 13 |
| FQ2 2027 (Apr 2027) | 0.03B | -- | 0.03B | 0.03B | 9 |
| FQ4 2026 (Oct 2026) | 0.03B | -35.77 | 0.03B | 0.03B | 15 |
| FQ3 2026 (Jul 2026) | 0.03B | -29.3 | 0.03B | 0.03B | 9 |
| FQ2 2026 (Apr 2026) | 0.03B | -26.75 | 0.03B | 0.03B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0 | 0.05 | 0.05 | 100% |
| FQ3 2025 (Jul 2025) | 0 | -0.16 | -0.16 | 100% |
| FQ2 2025 (Apr 2025) | -0.05 | -0.05 | 100% | |
| FQ1 2025 (Jan 2025) | -2.07 | -2.07 | 100% | |
| FQ4 2024 (Nov 2024) | 1.53737 | 0.0319 | -1.50547 | -4719.34% |
| FQ3 2024 (Aug 2024) | -0.0414 | -0.0414 | 100% | |
| FQ2 2024 (Apr 2024) | 0.16 | 0.16 | 100% | |
| FQ1 2024 (Jan 2024) | 0.36 | 0.36 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.04B | $0.04B | $2.44M | 6.22% |
| FQ3 2025 (Jul 2025) | $0.04B | $0.04B | $-2.26M | -6.27% |
| FQ2 2025 (Apr 2025) | $0B | $0.04B | $37.71M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.04B | $37.36M | 100% |
| FQ4 2024 (Nov 2024) | $0.08B | $0.04B | $-34.68M | -85.78% |
| FQ3 2024 (Aug 2024) | $0B | $0.04B | $40.54M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.03B | $32.96M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.04B | $39.59M | 100% |